Mark Levin is a co-founder of Third Rock Ventures with over 40 years of experience, including more than 30 years launching and building biotechnology companies. Mark contributes as an advisor to our Fund IV portfolio companies and will continue to play active board roles in our current Fund I, II and III portfolio companies, including:
- Chairman of the board of Fulcrum Therapeutics
- Chairman of the board of Voyager Therapeutics
- Board member of Corvia Medical
- Board member of NinePoint Medical
Prior to Third Rock, Mark was as Eli Lilly, Genentech, Mayfield Fund and Millennium Pharmaceuticals.